Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration -: Measurement of compound K by enzyme immunoassay

被引:0
|
作者
Akao, T [1 ]
Kanaoka, M [1 ]
Kobashi, K [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan
关键词
compound K; ginsenoside Rb-1; enzyme immunoassay; absorption; rat plasma; Panax ginseng;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Enzyme immunoassay (EIA) for the determination of compound It (C-K), a major metabolite of ginsenoside Rb-1 (G-Rb-1) from Panax ginseng root by intestinal bacterial flora, was explored. Bovine serum albumin (BSA) was coupled to the C-26 position on the unsaturated side chain of C-K. beta-D-Galactosidase was introduced at the C-26 position of the saturated side chain. Antiserum, obtained by immunization of rabbits with C-K-BSA conjugate, possesed high affinity and specificity toward C-K. The EIA for C-K by the double antibody method was established in the range of 0.1-100 ng/tube. Plasma C-K after the oral administration of C-K and G-Rb-1 to rats was determined by the established EIA. C-K was rapidly absorbed from the gastrointestinal tract after the administration, then slowly decreased. On the other hand, C-K appeared late and was retained for a long period of time in the plasma after the administration of G-Rb-1, which itself is hardly absorbed.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 41 条
  • [31] Cloning and Characterization of Ginsenoside-Hydrolyzing β-Glucosidase from Lactobacillus brevis That Transforms Ginsenosides Rb1 and F2 into Ginsenoside Rd and Compound K
    Zhong, Fei-Liang
    Ma, Rui
    Jiang, Mingliang
    Dong, Wei-Wei
    Jiang, Jun
    Wu, Songquan
    Li, Donghao
    Quan, Lin-Hu
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2016, 26 (10) : 1661 - 1667
  • [32] Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1
    Zhou, Wei
    Li, Jiyang
    Li, Xinwei
    Yan, Qin
    Zhou, Pei
    JOURNAL OF SEPARATION SCIENCE, 2008, 31 (6-7) : 921 - 925
  • [33] Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings
    Choi, Min-Koo
    Jin, Sojeong
    Jeon, Ji-Hyeon
    Kang, Woo Youl
    Seong, Sook Jin
    Yoon, Young-Ran
    Han, Yong-Hae
    Song, Im-Sook
    JOURNAL OF GINSENG RESEARCH, 2020, 44 (02) : 229 - 237
  • [34] Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide
    Park, EK
    Shin, YW
    Lee, HU
    Kim, SS
    Lee, YC
    Lee, BY
    Kim, DH
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) : 652 - 656
  • [35] Simultaneous determination of ginsenoside Rb1, naringin, ginsenoside Rb2 and oridonin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Weifuchun tablet
    Jin, Yiran
    Tian, Tingting
    Ma, Yinghua
    Xu, Huijun
    Du, Yingfeng
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2015, 1000 : 112 - 119
  • [36] Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue
    Chen, Weijie
    Wang, Junlian
    Luo, Yong
    Wang, Tao
    Li, Xiaochun
    Li, Aiyun
    Li, Jia
    Liu, Kang
    Liu, Baolin
    JOURNAL OF GINSENG RESEARCH, 2016, 40 (04) : 351 - 358
  • [37] Pharmacokinetics of Ginsenoside Rb1, Rg3, Rk1, Rg5, F2, and Compound K from Red Ginseng Extract in Healthy Korean Volunteers
    Kim, Hyung Joong
    Oh, Tae Kyu
    Kim, Yoon Hee
    Lee, Jaesun
    Moon, Joo Myung
    Park, Yong Sun
    Sung, Chang Min
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [38] Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism
    Zhang, Kang-Xi
    Zhu, Yue
    Song, Shu-Xia
    Bu, Qing-Yun
    You, Xiao-Yan
    Zou, Hong
    Zhao, Guo-Ping
    MOLECULES, 2024, 29 (05):
  • [39] Enhanced Absorption Study of Ginsenoside Compound K (20-O-β-(D-Glucopyranosyl)-20(S)-protopanaxadiol) after Oral Administration of Fermented Red Ginseng Extract (HYFRG™) in Healthy Korean Volunteers and Rats
    Choi, Il-Dong
    Ryu, Ju-Hee
    Lee, Dong-Eun
    Lee, Myoung-Hee
    Shim, Jae-Joong
    Ahn, Young-Tae
    Sim, Jae-Hun
    Huh, Chul-Sung
    Shim, Wang-Seob
    Yim, Sung-Vin
    Chung, Eun-Kyoung
    Lee, Kyung-Tae
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [40] Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury
    Park, Eun-Seok
    Lee, Kang Pa
    Jung, Seung Hyo
    Lee, Dong-Youb
    Won, Kyung Jong
    Yun, Yeo-Pyo
    Kim, Bokyung
    ATHEROSCLEROSIS, 2013, 228 (01) : 53 - 60